RxSpan MD Weight Loss: Compounded Semaglutide and Tirzepatide Options Weight loss is RxSpan MD's headline category, built around GLP-1 medications
New Ozempic Side Effect Updates On July 3, 2024, researchers published a study in JAMA Ophthalmology reporting that patients with Type 2 diabetes or who were overweight and took semaglutide-containing medications had significantly higher risks for developing non-arteritic anterior ischemic optic neuropathy (NAION)
These effects contribute to weight loss, making semaglutide valuable for diabetes and weight management
In wellness IVs, we usually dont have harsh vesicants, so extravasation isnt a major concern
The medication slows gastric emptying, which means heavy, fatty proteins sit in your stomach longer and can trigger bloating , nausea, and discomfort
[6] IQVIA Institute for Human Data Science